Industry: Healthcare
Published Date: April-2025
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 250
Report ID: PMRREP4147
Newly-released Mammography industry analysis report by Persistence Market Research shows that global sales of Mammography in 2024 were held at US$ 2,987.80 Million. With a CAGR of 9.9% from 2025 to 2032, the market is projected to reach a valuation of US$ 6,288.7 Million by 2032. Digital Systems are expected to be the highest revenue-generating product type, which is expected to grow at a CAGR of 9.9% from 2025 to 2032.
Attribute |
Details |
Mammography Market Size (2025) |
US$ 3,247.7 Million |
Projected Market Value (2032) |
US$ 6,288.7 Million |
Global Market Growth Rate (2025 to 2032) |
9.9% |
Historical Market Growth Rate (CAGR 2019 to 2024) |
8.7% |
Key Companies Profiled |
|
As per the Mammography industry research by Persistence Market Research - a market research and competitive intelligence provider, historically, from 2019 to 2024, the market value of the Mammography industry increased at around 9.4% CAGR, wherein, countries such as the U.S., China, Japan, U.K., and South Korea held a significant share in the global market.
Breast cancer is more common in the elderly and those who suffer from hormonal abnormalities. Menopausal hormone therapy, for example, raises the risk of breast cancer after menopause. The global market for mammography is likely to be driven by several factors, including an aging population and an increase in the number of cases of hormonal imbalances.
This industry is also projected to be driven by increased awareness of mammography procedures. However, barriers to market growth include lack of awareness, patient discomfort, and adverse effects associated with mammography.
The worldwide market is being driven by a rapid increase in the number of breast cancer cases, technical breakthroughs in breast imaging techniques, and increased actions and funding by government and private organizations for breast cancer monitoring programs. Owing to this, Mammography Market is projected to grow at a CAGR of 9.9% over the coming 10 years.
Mammography has become one of the most sophisticated methods for detecting breast cancer early. It has substantially aided medical authorities in reducing the global burden of breast cancer. The rising prevalence of breast cancer is driving the growth of the mammography industry. Breast cancer was diagnosed in around 2.3 million women worldwide in 2020, according to the World Health Organization. It must be detected early in order to begin adequate treatment and, as a result, increase the odds of survival. As a result, the mammography method is becoming more widely employed in healthcare institutions.
Similarly, rising incidences of hormonal imbalance, an aging population, and increased awareness among women about breast cancer, its detection, and treatment will continue to drive mammography equipment sales in the future.
Furthermore, technical improvements in mammography systems, such as the introduction of 3-D imaging solutions and an increase in the number of hospitals, diagnostic centers, and specialized centers, are expected to propel the market forward in the forthcoming years.
Mammography is a non-invasive medical imaging and diagnostic procedure that employs low-dose X-rays to check for tumors in the breast tissue. It has become one of the most widely utilized methods for detecting aBillionormalities when there are no symptoms. It has made a substantial contribution to the worldwide reduction in breast cancer mortality.
Many mammography solutions or types, such as breast tomosynthesis, film screen systems, and X-rays, are employed for the early detection of breast cancer. Often known as screen-film mammography, film-screening systems are still the gold standard for detecting breast cancer.
Various government and non-government groups are investing heavily in breast cancer screening in order to reduce the total burden. This will continue to generate market growth with tailwinds in the future. Furthermore, the availability of advantageous reimbursement policies in many developed areas is boosting the market growth.
Despite the growing popularity of mammography for breast cancer diagnosis, a number of difficulties are limiting market expansion to a great extent. Radiation risk, significant capital expenditure, and a lack of information regarding mammography equipment are some of the key factors in several emerging and poor regions of the world.
Which Region is projected to Offer the Largest Opportunity for Mammography?
With a CAGR of over 11% from 2025 to 2032, North America is expected to remain the largest market throughout the analysis period. Due to multiple mergers, partnerships, and acquisitions by key players, the regional market is expected to grow at a significant pace during the forecast period, grossing an absolute dollar opportunity of US$ over 2 Billion from 2025 to 2032.
U.S. Mammography Market Analysis
The market in the U.S. is projected to reach a valuation of US$ 2.2 Billion by 2032. Due to the rising prevalence of breast cancer, rising awareness among people about the importance of diagnostic screening for initiating early treatment, and increased spending by government and private organizations in research and development activities, the U.S. is expected to maintain its dominance in the global market. Because of increased breast cancer rates, the availability of sophisticated diagnostic methods, and favorable government funding, the United States remains the most lucrative market for mammography in North America.
In 2022, the American Cancer Society estimates that 287,850 new instances of invasive breast cancer will be identified in the United States. During the projected period, this will continue to boost the mammography market in the United States.
U.K. Mammography Market Analysis
The market in the U.K. is expected to reach a valuation of US$ 318 Million by 2032. Growing with a CAGR of 12.1% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around US$ 215.9 Million.
Japan Mammography Market Analysis
In Japan, the market is expected to grow at a CAGR of 13.2% from 2023 to 2033, reaching around US$ 298 Million by 2032. The market in the country is expected to gross an absolute dollar opportunity of US$ 211.3 Million during the forecast period.
South Korea Mammography Market Analysis
The market in South Korea is expected to reach a valuation of around US$ 129.1 Million by 2032, growing at a CAGR of 9.4% from 2025 to 2032. The market in the country is expected to witness an absolute dollar opportunity of around US$ 77.6 Million.
Which Mammography Product Type will be most preferred?
The Digital System segment is the most preferred in the mammography market, which is expected to grow at a CAGR of 9.9% from 2025 to 2032. One of the key factors likely to increase sales is a surge in demand for technologically advanced breast cancer-screening systems. 3D-based mammography is projected to garner significant growth in the forthcoming years. The Medical Imaging Modernization Act of 2015, which was enacted to promote technological advances, resulted in significant growth in the 3D systems-based mammography market.
Key players in the Mammography Market include Hologic Inc., Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, Koninklijke Philips NV, and PLANMED OY.
A few recent developments of key Mammography providers are as follows:
Similarly, recent developments in the Mammography Market have been tracked by the team at Persistence Market Research, which is available in the full report.
By Product Type
By Technology
By Region
To know more about delivery timeline for this report Contact Sales
The global mammography market was valued at US$ 2,987.80 million in 2024.
The market is expected to reach US$ 6,288.7 million by 2032.
The market is projected to grow at a CAGR of 9.9% during this period.
The U.S., China, Japan, U.K., and South Korea are leading contributors to market share.
Key companies include Hologic Inc., Fujifilm Corporation, GE Healthcare, Siemens Healthcare, and Canon Medical Systems Corporation, among others.